Enzo Biochem, Inc. (ENZ)

NYSE: ENZ · IEX Real-Time Price · USD
1.340
0.00 (0.00%)
Feb 27, 2024, 4:00 PM EST - Market closed
0.00%
Market Cap 67.66M
Revenue (ttm) 20.59M
Net Income (ttm) 24.31M
Shares Out 50.49M
EPS (ttm) 0.50
PE Ratio 2.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 116,849
Open 1.390
Previous Close 1.340
Day's Range 1.335 - 1.390
52-Week Range 1.000 - 2.740
Beta 0.73
Analysts n/a
Price Target n/a
Earnings Date Mar 19, 2024

About ENZ

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes ... [Read more]

Sector Healthcare
Founded 1976
Employees 179
Stock Exchange NYSE
Ticker Symbol ENZ
Full Company Profile

Financial Performance

Financial Statements

News

Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held o...

26 days ago - GlobeNewsWire

ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

FARMINGDALE, NY, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023.

2 months ago - GlobeNewsWire

Steven J. Pully Appointed to Enzo Biochem's Board of Directors

FARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or “the Company”), a leading life sciences company, announced today that Steven J. Pully has been appointed to...

4 months ago - GlobeNewsWire

Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO

FARMINGDALE, NY, Sept. 06, 2023 (GLOBE NEWSWIRE) --  Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Direc...

6 months ago - GlobeNewsWire

Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

Significant value unlocked for Enzo shareholders with continued focus on life sciences. FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has clo...

7 months ago - GlobeNewsWire

Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

- Enzo Life Sciences reports revenue of $7.5 million, with margin improvement in Q3 FY23 FARMINGDALE, NY, June 14, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences and ...

9 months ago - GlobeNewsWire

Federman & Sherwood Investigates Enzo Biochem for Data Breach

OKLAHOMA CITY--(BUSINESS WIRE)-- #DataBreach--The law firm of Federman & Sherwood has initiated an investigation into Enzo Biochem with respect to their recent data breach. On May 30, 2023, Enzo Bioch...

9 months ago - Business Wire

Enzo Biochem says ransomware attack exposed clinical test data of 2.5 million patients

Enzo Biochem, a New York-based biotechnology company, has confirmed that a ransomware attack exposed the clinical test information of almost 2.5 million patients.

9 months ago - TechCrunch

Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

FARMINGDALE, NY, May 22, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), announced today that  the preliminary voting results from the Inspector of Election at today's Special Meeting of the S...

10 months ago - GlobeNewsWire

SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

NEW YORK , May 2, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enzo Biochem, Inc. ("Enzo Biochem" or the...

Other symbols: LH
10 months ago - PRNewsWire

Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders

FARMINGDALE, NY, April 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo Biochem” or the “Company”), a leading biosciences and diagnostics company, today announced that its special me...

11 months ago - GlobeNewsWire

Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results

- Company entered into an Asset Purchase Agreement for substantially all of the operating assets of the Clinical Labs division

1 year ago - GlobeNewsWire

Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp

Significant value unlocked for Enzo shareholders with continued focus on remaining businesses.

1 year ago - GlobeNewsWire

Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update

- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX

1 year ago - GlobeNewsWire

Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th

Conference Call and Webcast Scheduled for December 13 th , 8:30 AM ET

1 year ago - GlobeNewsWire

Enzo Biochem, Inc. Announces Date of Annual Shareholders' Meeting

NEW YORK, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced that its Annual Shareholders' M...

1 year ago - GlobeNewsWire

Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO

- David Bench resigning to pursue a new career opportunity - - David Bench resigning to pursue a new career opportunity -

1 year ago - GlobeNewsWire

Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update

- Enzo Life Sciences reports revenue of $32.6 million and 8% growth in FY 2022, net of FX

1 year ago - GlobeNewsWire

Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th

Conference Call and Webcast Scheduled for October 1 4 , 202 2 , 8 : 3 0 a m ET

1 year ago - GlobeNewsWire

Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2

Powered by Enzo's LoopRNA™ ISH technology, a new platform designed for superior sensitivity in detection and visualization of biomarkers in the spatial context of cells and tissues Powered by Enzo's L...

1 year ago - GlobeNewsWire

Enzo Biochem to Launch Monkeypox Testing Services this Week

NEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that its full-service clinical ...

1 year ago - GlobeNewsWire

Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor

Conference call and live webcast scheduled for tomorrow, Friday, June 10, 2022 at 8:30 am (ET)

1 year ago - GlobeNewsWire

UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th

Conference Call and Webcast Scheduled for June 10, 2022, 8:30 am ET Conference Call and Webcast Scheduled for June 10, 2022, 8:30 am ET

1 year ago - GlobeNewsWire

Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th

Conference Call and Webcast Scheduled for June 9, 2022, 4:30 pm ET

1 year ago - GlobeNewsWire

Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal

Meeting Scheduled for April 8, 2022 at 9:00 AM ET

2 years ago - GlobeNewsWire